Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation
Abstract Necroptosis, a type of programmed cell death, has been increasingly linked to cardiovascular disease development, yet its role in dilated cardiomyopathy (DCM) remains unclear. In this study, we analyzed the GSE5406 dataset from the GEO database to explore necroptosis-related prognostic sign...
Saved in:
Main Authors: | Han Yang, Zhenwei Wang, Yawei Xu, Yimei Du, Haibo Yang, Yang Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-83455-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Construction of a Novel Necroptosis-Related Signature in Rat DRG for Neuropathic Pain
by: Liu Y, et al.
Published: (2025-01-01) -
Analysis of MLKL, RIP1 and RIP3 Immunostaining Markers in Human Liver Tissue from Fatal Yellow Fever Cases: Insights into Necroptosis
by: Vanessa do Socorro Cabral Miranda, et al.
Published: (2024-12-01) -
Screening of necroptosis-related genes and evaluating the prognostic capacity, clinical value, and the effect of their copy number variations in acute myeloid leukemia
by: Dake Wen, et al.
Published: (2025-01-01) -
Dilated cardiomyopathy and myocarditis: a clinical case
by: O.V. Onyshchenko, et al.
Published: (2023-12-01) -
Necroptosis could serve as an indicator of therapeutic resistance in viral induced well-differentiated oral squamous cell carcinoma?
by: Nitya Krishnasamy, et al.
Published: (2024-06-01)